Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Porreca

Showing results (231-240 of 293) with videos related to

Pageof 30
Sort By:
Journal of Medicinal Chemistry|November 11, 1994
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11J P Meyer, N Collins, F D Lung, et al.
Journal of Neurochemistry|February 1, 1995
Retrovirus-mediated expression of an artificial beta-endorphin precursor in primary fibroblastsA S Beutler, M S Banck, F W Bach, et al.
Brain Research|July 21, 1999
Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserumD Bian, M H Ossipov, M Ibrahim, et al.
European Journal of Pharmacology|August 15, 1993
Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodiumK D Wild, L Fang, R W McNutt, et al.
Life Sciences|June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of painV J Hruby, R S Agnes, P Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtypeA Mattia, S C Farmer, A E Takemori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2006
Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonistF Porreca, T W Vanderah, W Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneityL Fang, R J Knapp, R Horvath, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 1, 2001
Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin IS Liao, M Shenderovich, K E Kövér, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalinA W Lipkowski, A Misicka, P Davis, et al.
Pageof 30

Showing results (231-240 of 293) with videos related to

Sort By:
Pageof 30
Journal of Medicinal Chemistry|November 11, 1994
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11J P Meyer, N Collins, F D Lung, et al.
Journal of Neurochemistry|February 1, 1995
Retrovirus-mediated expression of an artificial beta-endorphin precursor in primary fibroblastsA S Beutler, M S Banck, F W Bach, et al.
Brain Research|July 21, 1999
Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserumD Bian, M H Ossipov, M Ibrahim, et al.
European Journal of Pharmacology|August 15, 1993
Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodiumK D Wild, L Fang, R W McNutt, et al.
Life Sciences|June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of painV J Hruby, R S Agnes, P Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtypeA Mattia, S C Farmer, A E Takemori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2006
Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonistF Porreca, T W Vanderah, W Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneityL Fang, R J Knapp, R Horvath, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 1, 2001
Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin IS Liao, M Shenderovich, K E Kövér, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalinA W Lipkowski, A Misicka, P Davis, et al.
Pageof 30